ConvaTec Group Plc (LON:CTEC) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 225 ($2.94) and last traded at GBX 224.20 ($2.93), with a volume of 2868188 shares traded. The stock had previously closed at GBX 218.20 ($2.85).
Separately, Shore Capital reiterated a “buy” rating on shares of ConvaTec Group in a research report on Thursday, April 29th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 204.14 ($2.67).
The stock has a 50 day simple moving average of GBX 200.32 and a two-hundred day simple moving average of GBX 199.08. The company has a market cap of £4.52 billion and a price-to-earnings ratio of 53.22. The company has a debt-to-equity ratio of 93.15, a current ratio of 2.30 and a quick ratio of 1.67.
In other ConvaTec Group news, insider Frank Schulkes sold 3,658 shares of the business’s stock in a transaction on Monday, March 8th. The stock was sold at an average price of GBX 190 ($2.48), for a total transaction of £6,950.20 ($9,080.48).
ConvaTec Group Company Profile (LON:CTEC)
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes.
Featured Article: What are Bollinger Bands?
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.